PCRX

Pacira Biosciences Inc

• Reuters·10h ago

  Pacira grants inducement equity awards to new hires, sets options exercise price at $22.7

• Reuters·03/30 12:05

  Pacira says EXPAREL lowers total cost of care in real-world orthopedic studies

• Dow Jones·03/26 12:56

  Pacira BioSciences Is Maintained at Equal-Weight by Barclays

• Dow Jones·03/26 12:56

  Pacira BioSciences Price Target Cut to $25.00/Share From $27.00 by Barclays

• Benzinga·03/26 12:46

  Barclays Maintains Equal-Weight on Pacira BioSciences, Lowers Price Target to $25

• TipRanks·03/26 10:30

  Pacira price target lowered to $25 from $27 at Barclays

• Reuters·03/26 10:11

  PACIRA BIOSCIENCES <PCRX.O>: BARCLAYS CUTS TARGET PRICE TO $25 FROM $27

• TipRanks·03/26 07:40

  Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX), Pacira Pharmaceuticals (PCRX) and Alnylam Pharma (ALNY)

• Reuters·03/26 07:38

  U.S. RESEARCH ROUNDUP- Equitable Holdings, Robinhood Markets, Wingstop

• Benzinga·03/25 12:02

  Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

• TipRanks·03/20 11:59

  J.P. Morgan Sticks to Their Sell Rating for Pacira Pharmaceuticals (PCRX)

• TipRanks·03/20 02:02

  Insider Shake-Up at Pacira Pharmaceuticals Sparks Fresh Investor Buzz

• Reuters·03/19 21:43

  Pacira BioSciences Chief Medical Officer Jonathan Slonin disposes of USD 74,411 in common shares

• Reuters·03/19 21:43

  Pacira BioSciences Director Mark Froimson Disposes of USD 10,905 in Common Shares

• Reuters·03/12 13:20

  BUZZ-U.S. STOCKS ON THE MOVE-SciSparc, Natera, US energy companies